Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Neurology

Results: 1-25/2256

Authors: MILLER R SWASH M
Citation: R. Miller et M. Swash, THERAPEUTIC ADVANCES IN ALS, Neurology, 47(6), 1996, pp. 217-217

Authors: JERUSALEM F POHL C KARITZKY J RIES F
Citation: F. Jerusalem et al., ALS, Neurology, 47(6), 1996, pp. 218-220

Authors: LEIGH PN MELDRUM BS
Citation: Pn. Leigh et Bs. Meldrum, EXCITOTOXICITY IN ALS, Neurology, 47(6), 1996, pp. 221-227

Authors: LUDOLPH AC
Citation: Ac. Ludolph, ANIMAL-MODELS FOR MOTOR-NEURON DISEASES - RESEARCH DIRECTIONS, Neurology, 47(6), 1996, pp. 228-232

Authors: DOBLE A
Citation: A. Doble, THE PHARMACOLOGY AND MECHANISM OF ACTION OF RILUZOLE, Neurology, 47(6), 1996, pp. 233-241

Authors: LACOMBLEZ L BENSIMON G LEIGH PN GUILLET P POWE L DURRLEMAN S DELUMEAU JC MEININGER V PUECH AJ WHITEHEAD J ASSELAIN B CESARO P LARREY D ROSSOR M ZIMMERMAN HJ SALZMAN P DOPPLER V LLOYD CM MALOTEAUX JM DELWAIDE C LATERRE EC BOUCHARD JP DUQUETTE P GIRARD M MASSE C EISEN A BLIN O AZULAY JP BILLETURC F POUGET J BOUCHE P CAMU M CARLANDER B BILLIARD M CLANET M ANGIBAUD G ARNEBES MC BENAZET M COURATIER P VALLAT JM DESNUELLE C LAGUENY A ELLIE E DIB M ROZIER A SALACHAS F VIADER F DELAUNAY D DENGLER R KUTHER G TROGER M LUDOLPH A BACHUS R GERICKE C PRZUNTEK H LANGKAFEL M SCHIMRIGK K JOST WH OSTERHAGE J PRUDLO J MORA J CHAVERRI D SAENZ E JEFFERSON D ORPE V LANE RJM ORRELL RW BARBIE T MITCHELL JD KILSHAW J PALL HS GOODWIN M SCHADY W DUNCAN S MOORE C RICHARDS C SHAW PJ CHARI G PICKERING B SWASH M HARATI Y GOOCH CL ECHOLS CW MILLER RG GELINAS DF QUIEN A MUNSTAT TL THORNELL B ROTHSTEIN JD CLAWSON L SUFIT R CASEY P DELUMEAU J TRUFFINET P DEBOVE C ENFRIN P HAMPTON G MULLER F NGUYEN T ROTHFUSS D SENECHAL A SHU C LESWELL P WHITWORTH P DEBOE M DEBRUYCKERE M FISHER W KONIG M VERDUGO L DELOSTERREROS MS DEAKIN D GIGUERE M ADAIR K FRANCO M SKARINSKY D WEXLER M PIZZATO M LEDOUX L CAMPAGNES E HARTNETT M BASTIEN P BEJUIT R KIM Y LELANN L LEROY F PAPILLON C ORVOENFRIJA E
Citation: L. Lacomblez et al., A CONFIRMATORY DOSE-RANGING STUDY OF RILUZOLE IN ALS, Neurology, 47(6), 1996, pp. 242-250

Authors: HUGON J
Citation: J. Hugon, ALS THERAPY - TARGETS FOR THE FUTURE, Neurology, 47(6), 1996, pp. 251-254

Authors: GERLACH M YOUDIM MBH RIEDERER P
Citation: M. Gerlach et al., PHARMACOLOGY OF SELEGILINE, Neurology, 47(6), 1996, pp. 137-145

Authors: POEWE WH WENNING GK
Citation: Wh. Poewe et Gk. Wenning, THE NATURAL-HISTORY OF PARKINSONS-DISEASE, Neurology, 47(6), 1996, pp. 146-152

Authors: LANGSTON JW
Citation: Jw. Langston, THE ETIOLOGY OF PARKINSONS-DISEASE WITH EMPHASIS ON THE MPTP STORY, Neurology, 47(6), 1996, pp. 153-160

Authors: JENNER P OLANOW CW
Citation: P. Jenner et Cw. Olanow, OXIDATIVE STRESS AND THE PATHOGENESIS OF PARKINSONS-DISEASE, Neurology, 47(6), 1996, pp. 161-170

Authors: TATTON WG CHALMERSREDMAN RME
Citation: Wg. Tatton et Rme. Chalmersredman, MODULATION OF GENE-EXPRESSION RATHER THAN MONOAMINE-OXIDASE INHIBITION - (-)-DEPRENYL-RELATED COMPOUNDS IN CONTROLLING NEURODEGENERATION, Neurology, 47(6), 1996, pp. 171-183

Authors: FAHN S
Citation: S. Fahn, IS LEVODOPA TOXIC, Neurology, 47(6), 1996, pp. 184-195

Authors: KOLLER WC
Citation: Wc. Koller, SELEGILINE MONOTHERAPY IN THE TREATMENT OF PARKINSONS-DISEASE, Neurology, 47(6), 1996, pp. 196-199

Authors: MYLLYLA VV SOTANIEMI K MAKIIKOLA O RINNE UK HEINONEN EH
Citation: Vv. Myllyla et al., ROLE OF SELEGILINE IN COMBINATION THERAPY OF PARKINSONS-DISEASE, Neurology, 47(6), 1996, pp. 200-209

Authors: OLANOW CW
Citation: Cw. Olanow, SELEGILINE - CURRENT PERSPECTIVES ON ISSUES RELATED TO NEUROPROTECTION AND MORTALITY, Neurology, 47(6), 1996, pp. 210-216

Authors: DAROFF RB
Citation: Rb. Daroff, A DECADE ENDS - THE EDITOR LEAVES, Neurology, 47(6), 1996, pp. 1365-1367

Authors: JOYNT RJ
Citation: Rj. Joynt, THE 4TH EDITOR-IN-CHIEF OF NEUROLOGY - GRIGGS,ROBERT,C, Neurology, 47(6), 1996, pp. 1368-1368

Authors: KAUFMANN H
Citation: H. Kaufmann, COULD TREATMENT WITH DOPS DO FOR AUTONOMIC FAILURE WHAT DOPA DID FOR PARKINSONS-DISEASE, Neurology, 47(6), 1996, pp. 1370-1371

Authors: DELLOSSO LF
Citation: Lf. Dellosso, SEE-SAW NYSTAGMUS IN DOGS AND HUMANS - AN INTERNATIONAL, ACROSS-DISCIPLINE, SERENDIPITOUS COLLABORATION, Neurology, 47(6), 1996, pp. 1372-1374

Authors: FISHER CM
Citation: Cm. Fisher, HYPOMANIC SYMPTOMS CAUSED BY HERPES-SIMPLEX ENCEPHALITIS, Neurology, 47(6), 1996, pp. 1374-1378

Authors: IVERSON DJ
Citation: Dj. Iverson, BENCHMARKING GRADUATE MEDICAL-EDUCATION IN NEUROLOGY - A CROSS-SPECIALTY COMPARISON AND ANALYSIS OF RESIDENCY MATCHING DATA, Neurology, 47(6), 1996, pp. 1379-1382

Authors: MILLER RG MOORE D YOUNG LA ARMON C BAROHN RJ BROMBERG MB BRYAN WW GELINAS DF MENDOZA MC NEVILLE HE PARRY GJ PETAJAN JH RAVITS JM RINGEL SP ROSS MA QUIEN A MURPHY J BRINKMAN J BURNS D PARSONS J BRAIMAN J KELKAR P HARTSOCK L HEFFNER M MOSES D RIDDLE K FURTADO M DOYLE J GRAVES J AULENBACHER D HERBELIN L IVY N FORSHEW D MASON V TRAFTON L BARBEE M GAROFALO E HAYES L LEIDERMAN D PIERCE M
Citation: Rg. Miller et al., PLACEBO-CONTROLLED TRIAL OF GABAPENTIN IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS, Neurology, 47(6), 1996, pp. 1383-1388

Authors: THAL LJ SCHWARTZ G SANO M WEINER M KNOPMAN D HARRELL L BODENHEIMER S ROSSOR M PHILPOT M SCHOR J GOLDBERG A
Citation: Lj. Thal et al., A MULTICENTER DOUBLE-BLIND-STUDY OF CONTROLLED-RELEASE PHYSOSTIGMINE FOR THE TREATMENT OF SYMPTOMS SECONDARY TO ALZHEIMERS-DISEASE, Neurology, 47(6), 1996, pp. 1389-1395

Authors: KEENAN PA JACOBSON MW SOLEYMANI RM MAYES MD STRESS ME YALDOO DT
Citation: Pa. Keenan et al., THE EFFECT ON MEMORY OF CHRONIC PREDNISONE TREATMENT IN PATIENTS WITHSYSTEMIC-DISEASE, Neurology, 47(6), 1996, pp. 1396-1402
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>